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Common acute lymphocytic leukemia antigen (CALLA' ; CD10) is an important
cell surface marker in the diagnosis ofhuman acute lymphocytic leukemia (ALL)
(references 1-8) . It is present on leukemic cells of pre-B phenotype, which represent
85% of cases ofALL, and is absent from normal PBMC . However, CALLA is not
restricted to leukemic cells and is found on a variety of normal tissues (9-14) . It
is particularly abundant in kidney, where it is present on the brush border of prox-
imal tubules and on glomerular epithelium (2, 9, 10) . CALLA is a glycoprotein of
Mr 9.4 x 104-105 (4-11, 14-19) for which no functional activity has yet been de-
scribed . We report on the cloning of a cDNA coding for CALLA, and show that
the amino acid sequence deduced from the cDNA sequence is identical to that of
human membrane-associated neutral endopeptidase(NEP ; EC 3.4.24.11), also known
as enkephalinase. NEP cleaves peptides at the amino side of hydrophobic residues
(21, 22) and inactivates several peptide hormones including glucagon, enkephalins,
substance P, neurotensin, oxytocin, bradykinin, and the chemotactic peptide fMLF
(20-24) .
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Materials and Methods
Purification andPartial Sequencing ofCALLA.
￿
The production and purification of the 44C10
IgG2b mAb have been described previously (8). CALLA was purified from human kidney
cortex by Triton X-100 solubilization, and sequential affinity chromatography with nonim-
mune mouse IgG-Sepharose and monoclonal 44CIO IgG-Sepharose . The antigen was eluted
with 0.05 M diethylamine, pH 11.2, 0.1% Triton X-100, and was neutralized immediately ;
recovery ofantigen was estimated by inhibition ofa cellularRIA (8, 11) . The antigenic prepa-
ration was fractionated by SDS-PAGE, and the M, 9.4 x 104 protein band was eluted elec-
trophoretically . CNBr fragments were generated, fractionated by reversed-phase HPLC (25),
and analyzed in a gas-phase sequencer.
Isolation and Sequence Analysis ofa CALLA cDNA Clone.
￿
Mixed oligonucleotide probes cor-
responding to the sequences of peptides 1 and 2 (Fig . 1) were used to screen an oligo-dT
primed human kidney cDNA library inserted in the X gtl0 vector ; the library was the kind
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J . Exp. MED. C The Rockefeller University Press " 0022-1007/88/10/1247/07 $2.00
￿
12471248
￿
COMMON ACUTE LYMPHOCYTIC LEUKEMIA ANTIGEN
gift ofDr. Graeme Bell, Chiron Corp., Emeryville, CA. One clone was selected that hybrid-
ized to both probes; two Eco RI fragments (0.7 and 1 .6 kb) ofthis primary cDNA clone were
subdoned into the Bluescript vector (Stratagene, San Diego, CA), and sequenced on both
strands using the dideoxy chain terminator method. The sequences obtained were compared
with all sequences in the GenBank database (version 56, March 1988), using the algorithm
of Lipman and Pearson (26). The optimal alignment with rat NEP found by the computer
program did not contain any gaps, and was used as the basis for the protein sequence com-
parison shown in Fig. 1 .
Northern Blot Analysis.
￿
Total RNA was prepared from cultured cells by acid guanidinium
thiocyanate-phenol-choroform extraction (27). 20-pg aliquots were separated on a 1.2% agarose
gel under denaturing conditions and transferred to a nylon membrane (Hybond-N; Amer-
sham Corp., Arlington Heights, IL). Hybridization with the 1 .6-kb cDNA fragment labeled
by random priming was performed in 50% formamide, 5 x SSC, at 42°C, and the filter was
washed in 0.1 x SSC, 0.5% SDS at 55°C .
Results and Discussion
CALLA was purified from kidney extracts by immunoaffinity chromatography
using mAb 44C10, produced by immunisation with the CALLA-positive leukemic
cell line HOON (8), and reactive with the same epitope as other widely used anti-
CALLA mAb (2-8) . The M, of the antigens immunoprecipitated with mAb 44C10
were estimated at 9.4 x 104 (kidney) and 105 (NOON); after Endo F digestion, both
polypeptides had an apparent M, of 8 x 104. The CALLA glycoprotein was purified
on average 200-300-fold relative to the crude kidney extract. From a whole kidney
cortex, 6 mg ofprotein representing 40-50% ofthe CALLA antigenic activity were
recovered after immunoaffinity chromatography. The protein, purified an additional
12-fold by electrophoretic elution from polyacrylamide gels, migrated as a single
band; Mr, 9.4 x 104. The sequences of CNBr peptides 1 and 2 (Fig. 1) were deter-
mined for two independent preparations, with identical results.
A cDNA clone was isolated from a human kidney library using a mixed oligonucleo-
tide probe corresponding to the sequence ofpeptide 2 (MNPEKK). This clone (N3.4
kb) also hybridized with a mixed oligonucleotide probe derived from a partial se-
quence of peptide 1 (MVIGHE). We determined the nucleotide sequence of two
Eco RI fragments (0.7 and 1.6 kb) of this cDNA, and compared these sequences
with all entries in the GenBank nucleotide sequence database. Both fragments showed
a high degree ofsimilarity (86% and 91%, respectively) with the sequence of a cDNA
coding for the rat NEP (28). The 0.7-kb fragment corresponds to the 5' untranslated
and NH2-terminal coding regions, while the 1 .6-kb fragment covers two thirds of
the coding region.
Examination of more recent entries into the data banks revealed that both rabbit
(29) and human (20) NEP had also been cloned and sequenced . Compared with
the human NEP cDNA, the CALLA cDNA sequence was missing a 60-bp Eco RI
fragment between the two sequenced regions, and 39 bases of coding sequence be-
fore the termination codon. Translation of the CALLA cDNA into an amino acid
sequence confirmed that the protein is identical to human NEP and 95% identical
to rat or rabbit NEP (20, 21). Peptide 2, not found in the sequenced portion of the
CALLA cDNA, is identical to residues 741-746 of human and rabbit NEP.
The Tend of the CALLA cDNA clone extends 143 nucleotides further than the
human NEP cDNA clone and contains a stop codon located 6 by 5' of the first AUG
codon, as seen for rat and rabbit NEP (28, 29) . The main structural features ofNEPI
￿
80
NEP Rt GrSESQMDIT DINaPKPM QRWFLEISL SVLVLLLTiI AVTMIALYAT YDDGICKSSD CIKSAARLIQ NMDAaaEPCT
NEP Rb GrSESgMDIT DINUKPM QRWTPLEISL SVLVLLLTvI AVTMIALYAT YDDGICKSSD CIKSAARLIQ NMDAtaEPCT
CALLA
￿
GkSESQtR1IT DINtPKPKM QiWTPLEISL SVLVLLLTiI AVTMIALYAT YDDGICKSSD CIKSAARLIQ RWAttEPCT
NEP Hu
￿
kSESQMIT DINtPKPXKK QRWTPLEISL SVLVLLLTII AVTMIALYAT YDDGICKSSD CIXSAARLIQ NMDAttEPCT
1--ST_--I
￿
I-----Trensmombrane----- I
81
￿
160
NEP Rt DFFKYACGGW LKRNVIPETS SRYsNFDILR DELEViLKDV LQEMTEDIV AVQKAKtLYR SCOW= RGGgPLLtLL
NEP Rb DFFKYACGGW LKRNVIPETS SRYaNFDILR DELEViLXDV LQEPKTEDIV AVQKAKLLYR SCvNEtAIDS RWgFLLkLL
CALLA
￿
DFFKYACGM LKRNVIPETS SRY&MILR DELEVvLKDV LQEFKTEDIV AVQKAKaLYR SCOEsAIDS RGG*PLLkLL
NEP Hu DFFKYACG(W LKRNVIPETS SRYSNFDILR DELEVvLKDV LQEPKTEDIV AVQKAKaLYR SCOW= RWePLLkLL
wa*
161
￿
240
NEP Rt PDiYGWPVAs gNWEQtYGtS WtAEXsIAQL NSkYGKKVLI NFFVGTDDKN StgHiIHWQ PRLGLPSRDY YECTGIYKEA
NEP Rb PDvYGWPVAt gNWEQtYGtS WSAEK&IAQL NSnYGKKVLI NFFVGTDDKN SmnHiIHiDQ PRLGLPSRDY YECTGIYKEA
CALLA
￿
PDiYGWPVAt ONWEQkYGaS WtAEKaIAQL . . . . . . . . . .
￿
. .N SvnHvlHiVQ PRLGLPSRDY YECTGIYKEA
NEP Hu PDiYGWPVAt &NWEQkYGaS WtAEKaIAQL NSkYGKKVLI NLFVGTDDKN SvnEvIHiDQ PRLGLPSRDY YECTGIYKEA
241
￿
320
NEP Rt CTAYVDFMIs VArLIRQEgr LPIDENQlsl EMNXVMELEK EIANATtXpE DRNDPMLLYN XMtLAk1QNN FSLEINGKPF
NEP Rb CTAYVDFMIa VAkLIRQEe6 LPIDENQisv EMNKVMELEK ELANATtKsE DRNDFMLLYN KMtLAgiQNN FSLEINGKPF
CALLA
￿
CTAYVDFMIs VArLIRQEer LPIDENQlal EMBtXVMELEK EIANATaXpE DRNDPMLLYN KMtLAgiQNN FSLEINGKPF
NEP Hu CTAYVDFMIs VArLIRQEer LPIDENQlal EMNKVMiELEK EIANATaXpE DRNDPMLLYN KMpLAgiQNN FSLEINGKPF
321
￿
400
NEP Rt SWaNFTNEIM STVNInIgNE E®WVYAPEY LtXLKPILTK YspRDLQNLm SWRFIMDLVS SLSRnYKeSR NAFRKALYGT
NEP Rb SWsNFTNEIM STVNInIpNE EdVVVYAPEY LiXLKPILTK YfpRDFQNLf SWRFIMLVS SLSRtYKdSR NAFRKALYGT
CALLA
￿
SWINFTNEIM STVNIsItNE EdVVVYAPEY LLKLKPILTK YsaRDLQNLM SWRFIMLVS SLSRtYKeSR NAFRKALYGT
NEP flu SWINFTNEIM STVNI*ItNE EdWVYAPEY LLKLKPILTK YsaRDLQNLm SWRFIMDLVS SLSRtYKeSR NAFRKALYGT
*w* wwr
401
￿
480
NEP Rt TSEtATWRRC ANYVNGNMEN AVGRLYVEAA FAGESKHVVE DLIAQIREVF IQTLDDLTWM DAETKKkAEE KALAIKERIG
NEP Rb TSEsATWRRC ANYVNGNMHN AVGtLYVEAA FAGESKHVVE DLIAQIREVF IQTLDDLTWM DAETKKkAEE KALAIKERIG
CALLA
￿
TSEtATWRRC ANYVNGNMEN AVGRLYVEAA FAGESKHVVE DLIAQIREVF IQTLDDLTWM DAETKKrAEE KALAIKERIG
NEP Hu TSEtATWRRC ANYVNGNMEN AVGRLYVEAA FAGESKHVVE DLIAQIREVF IQTLDDLTWM DAETKKrAEE KALAIKERIG
481
￿
560
NEP Rt YPDDIiSNeN KLNNEYLELN YKEsEYFENI IQNLKFSQSK QLKKLREKVD KDEWIsGAAv VNAFYSSGRN QIVFPAGILQ
NEP Rb YPDDIVSNdN KLNNEYLELN YKEdEYFENI IQNLKFSQSK QLMQ.REKVD KDEWItGAAi VNAFYSSGRN QIVFPAGILQ
CALLA
￿
YPDDIVSNdN IQ.NNEYLELN YKEdEYFENI IQNLKFSQSK QLXKLREKVD KDEWIsGAAv VNAFYSSGRN QIVFPAGILQ
NEP Hu YPDDIvSNdN KLNNEYLELN YKEdEYFENI IQNLKFSQSK QLIIXLREKVD KDEWIsGAAv VNAFYSSGRN QIVFPAGILQ
561
￿
640
NEP Rt PPFFWQSN SLNYGGIGMV IGHEITHGFD DNGRNFNKDG DLVDWWTQQS AnNFKdQSW MVYQYGNFtW DLAGGQHLNG
NEP Rb FPFFSAgQSN SLNYGGIG+JV IGHEITHGFD DNGRNFNXDG DLVDWWT= AnNFKsQSQC MVYQYGNFsW DLAGGQHLNG
CALLA
￿
PPFFSAgQSN SLNYGGIGdV IGHEITBGFD DNGRNFNKDG DLVDWWTQQS AeNFKoQSQC MVYQYGNFsW DLAGGQHLNG
NEP Hu PPFFSAgQSN SLNYGGIGMV IGHEITHGFD DNGRNFNKDG DLVDWWTQQS AsNFKeQSQC MVYQYGNFsW DLAGGQHLNG
641
￿
720
NEP Rt INTLGENIAD NGGiGQAYRA YQNYVKKNGE EKLLPGIDLN HKQLFFLNFA QVWCGTYRPE YAVNSIKTDV HSPGNFRIIG
NEP Rb INTLGENIAD NGGiGQAYRA YQNYvMGE EKLLPGiDLN HKQLFFLNFA QVWCGTYRPE YAVNSIKTDV HSPGNFRIIG
CALLA
￿
INTLGENIAD NGGIGQAYRA YQNYiXKNGE EKLLPGIDLN HKQLFFLNFA QVWCGTYRPE YAVNSIKTDV HSPGNFRIIG
NEP Hu INTLGENIAD NGG1GQAYRA YQNYiKKNGE EKLLFGIDLN HKQLFFLNFA QVWCGTYRPE YAVNSIKTDV HSPGNFRIIG
721
￿
749
NEP Rt tLQNSaEFad AFhCrKNSYM NPErXCRVW
NEP Rb aLQNSvEFse AFgCpKNSYM NPEkKCRVW
CALLA
￿
tLQNSaRFse AFhCrK. . . . . .
￿
. . .
NEP Hu tLQNSaEFse AFhCrKNSYM NPEkKCRVW
I__2 __I
-___-______~
I--Zn- I
FIGURE 1.
￿
Protein sequencesof rat(Rt), rabbit (Rb), andhuman(Hu) NEP, andof theCALLA
antigen. Smallletters indicate positions where variations in sequence areobserved between spe-
cies. (. . .) Positions in the CALLA sequence still missing from the cDNA sequence. The fol-
lowing features are indicated below the sequences: the stop transfer (S7~ and transmembrane
fragments that give the protein its polarity (cytoplasmic NH2 terminus), the potential N-linked
glycosylation sitesfoundin thehumansequence ("""), andtheconsensuszinc-binding sequence
(Zn). ThesequencesofthetwoCALLA peptides (1 and2) used to design the mixedoligonucleo-
tide probes are also marked. Thesesequence data have been submittedto the EMBL/GenBank
Data Libraries under the accession number Y00811.1250
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are conserved between species : the transmembrane domain, the stop transfer se-
quence, the positions of the cysteine residues, the potential glycosylation sites (five
out of six), and the pentapeptide consensus sequence (H-E-[I, L, M]-x-H) of zinc-
binding metalloproteases (30, and Bouvier, J., A. Bairoch, and C. V . Jongeneel,
submitted for publication ; see Fig . 1) .
We probed Northern blots ofRNA extracted from twoleukemic cell lines,HOON
and NALM-6, and from human and mouse fibroblasts, with the 1.6-kb CALLA
cDNA fragment (Fig. 2). Theamounts ofCALLAmRNA correlated with theamounts
of CALLA detected at the cell surface by flow cytometry . The probe hybridized to
two RNA species of 3.8 and 6.6 kb. These sizes correspond to those described for
the rat NEPmRNAs (28) . In RNA extracted from NALM-6 cells, we could detect
one additional minor species of 5.0 kb . The same three mRNA species were ob-
served in human kidney, at a higher abundance than in NALM-6 ; however, they
were absent from RNA extracted from theTleukemia line Jurkat (datanot shown) .
No CALLA mRNA could be detected in mouse fibroblasts (Fig. 2) .
CALLA is avery useful diagnostic marker ofcommon (pre-B) ALL, being absent
from normal lymphocytes and monocytes ; it is however present on some stem cells
in fetal liver, bone marrow and thymus (12, 13), on some lymphomas (2, 3) and
on melanoma and glioma cell lines (17, 18) . It is, thus, neither leukemia specific
nor confined to a single tissue but is expressed on normal and neoplastic cells of
diverse origins . The presence of NEP on malignant cells or tissue has not been
documented . Both CALLA andNEP have been independently observed on epithe-
lial cells of kidney and gut (9-11, 21-23, 31), on neutrophils (14-16, 19, 24), and on
cultured fibroblasts (15, 32) . Within the kidney, where they are particularly abun-
dant, both CALLA and NEP are found on the brush border of proximal tubules
and on glomerular epithelium (9-11, 21-23, 31). CALLA antigens from leukemic
cells (4-8, 16), kidney (9, 11), melanoma (17), glioma (18), granulocytes (14, 15, 19),
or fibroblasts (15), and NEP from kidney (21-23, 28-29), brain (28), or fibroblasts
FIGURE 2 .
￿
Northern blot ofhuman leukemic cells and fibroblasts
probed withCALLAcDNA . RNA samples (20 pg) prepared from
theHOON (H) andNALM-6 (N) pre-BALL cell lines andfrom
human (HF) or mouse (MF) fibroblasts were fractionated on a
denaturing agarose gel . After transfer to anylon membrane, the
RNAs were probed with "P-labeled 1.6-kb CALLA cDNA
fragment .We thank J.-C. Cerottini for his critical reading of the manuscript, and E. Sexsmith and
A.-M. Lambonwah for theirhelp and advice. We gratefullyacknowledge the work ofA. Bairoch
and J. Bouvier in defining the signature of the zinc protease superfamily.
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(32), are all glycoproteins ofM, - 9 .4 x 104-105 . The variation in apparent Mr has
been attributed to heterogeneity of glycosylation.
NEP has been studied extensively in brain as an inactivator ofenkephalins; inhib-
itors of the enzyme have analgesic properties (28). Although there are no reports
of the presence of CALLA in brain, it has been described on several glioma cell
lines (18).
Kidney and neutrophil NEP can cleave the chemotactic peptide, fmLF, and poly-
clonal antibody to human kidney NEP can inhibit the hydrolysis of the tripeptide
by a neutrophil membrane fraction enriched in NEP (24). It is ofinterest that mAb
to CALLA can inhibit 20% of fMLF-induced neutrophil chemotaxis (19). Since
cleavage of chemotactic peptides is required for neutrophil degranulation and
chemotaxis, CALLA (NEP) might be important in neutrophil function (19, 24).
Our observation that the structure of CALLA corresponds to that of an enzyme
able to hydrolyze a variety of polypeptide hormones opens new avenues for testing
the function of this molecule in leukemic cells and its potential role in the process
of malignancy. In this context, it is of interest that transin, a zinc metalloprotease
belonging to the same superfamily as NEP, can be induced by oncogenes and is
expressed more abundantly in malignant than in benign tumors (33).
Summary
We purified CALLA from human kidney and isolated a cDNA clone reactive with
two oligonucleotide probes corresponding to two distinct peptides. The amino acid
sequence translated from the CALLA cDNA revealed 100% identity with that of
human neutral endopeptidase (NEP, enkephalinase). The distributions of CALLA
antigen and NEP in normal tissues are similar.
Note added in proof: The sequence of the CALLA cDNA has been completed and is identical
to that shown in Fig. 1 for human NEP. While this manuscript was in press, the sequence
of a CALLA cDNA isolated from the NALM-6 leukemic cell line has been reported (34)
and is identical to our sequence.
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